photo from fda.gov.ph
MANILA, Philippines—The Food and Drug Administration has warned the public against buying a batch of a peanut butter brand found to contain high levels of an “antinutrient” or toxin.
In an advisory dated March 31, FDA head Kenneth Hartigan Go said his agency had issued a product recall order on a batch of Lily’s Peanut Butter (170 grams) under Lot No. A1 10:26, after it was found to contain unacceptable levels of aflatoxin, a carcinogenic substance produced by a mold found in nuts, legumes and seeds.
The recalled peanut butter product has an expiry date of 052314, according to the FDA. It added that no other Lily’s peanut butter variants and sizes are affected by the recall.
According to the Department of Health, the toxin is a naturally occurring contaminant produced by mold that grows on crops, especially peanuts, that poses health risks when ingested in large amounts and over an extended period.
The FDA allows low levels of exposure to aflatoxins, not going beyond the acceptable limit of 20 parts per billion. Prolonged exposure to the toxin also increases the risk of developing cancer cells.
Aflatoxin is also known as an antinutrient substance that binds proteins, vitamins and minerals and prevents the body from absorbing nutrients. In children, it can stunt growth and cause kwashiorkor, a form of malnutrition resulting from inadequate protein intake.
Go said the manufacturer, Newborn Food Products Inc., has been ordered to “immediately recall” the particular product.
“All retail outlets carrying the product under the identified lot number are ordered to coordinate with the manufacturer regarding the recall and discontinue selling the affected product to the consumers,” he said.
Go said the public may send comments and queries to FDA’s email address, info@fda.gov.ph.
Go assured consumers that the FDA conducts continuous monitoring and market surveillance of all peanut-based food products to ensure public health.
RELATED STORY
One batch of Nagaraya nuts recalled for fungal toxin-fda